• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Novel Discovery and Functional Characterization of Key Genetic Variants that Influence the Pharmacogenomics of Anti-Platelet Therapy

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Backman_umaryland_0373D_10773.pdf
    Size:
    2.617Mb
    Format:
    PDF
    Download
    Author
    Backman, Joshua David
    0000-0001-7262-0880
    Advisor
    Shuldiner, Alan R.
    Lewis, Joshua P.
    Date
    2016
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    Coronary artery disease (CAD) is among the leading causes of death in the United States and worldwide. The most commonly prescribed treatment for the secondary prevention of cardiovascular events in at-risk patients is concurrent administration of clopidogrel and aspirin (DAPT). However, significant inter-individual variability in response has been documented, resulting in sub-optimal therapy in some patients and an increased risk of recurrent events. While genetic evaluations of ex vivo platelet reactivity have identified notable clopidogrel response modifiers such as CYP2C19*2, heritability estimates suggest most of the genetic determinants of variable DAPT response remain unidentified. We conducted the first genome-wide analysis of clopidogrel active metabolite concentration, a direct measure of clopidogrel pharmacokinetics, and discovered novel loci on chromosomes 3p25 and 17q11that significantly influence clopidogrel metabolism, as well as several other loci with suggestive evidence of association with clopidogrel response. While extension to on-clopidogrel platelet aggregation and ischemic events in an independent population was inconclusive, this research highlights the utility of clopidogrel active metabolite concentration as a novel endophenotype for clopidogrel efficacy. In addition to investigating novel antiplatelet response modifiers, we conducted clinical and functional characterization of rs12041331, a well-studied intronic variant in Platelet Endothelial Aggregation Receptor 1 (PEAR1) previously correlated with platelet aggregation and cardiovascular event risk. We used a fixed sequence, crossover design to prospectively evaluate platelet reactivity pre- and post- 3 different therapeutic aspirin doses in 67 healthy subjects recruited by rs12041331 genotype. rs12041331 was associated with platelet aggregation before and after aspirin exposure in a pathway- and agonist- specific manner, although higher aspirin dose did not impact platelet reactivity in a genotype-dependent manner. PEAR1 is also suggested to be a modifier of endothelial function. We therefore functionally characterized the impact of PEAR1 knockdown and rs12041331 on human umbilical vein endothelial cell (HUVEC) behavior in vitro and found PEAR1 to have a significant role in endothelial migration, extracellular matrix adhesion, and proliferation. While further follow-up is necessary, these experiments demonstrate the importance of incorporating multiple measures to evaluate genetic determinants of antiplatelet efficacy, and the results herein have promise to contribute to improved cardiovascular care in the future.
    Description
    University of Maryland, Baltimore. Human Genetics. Ph.D. 2016
    Keyword
    antiplatelet therapy
    clopidogrel
    PEAR1
    Aspirin
    Cardiovascular Diseases
    Pharmacogenetics
    Platelet Aggregation Inhibitors
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/6268
    Collections
    Theses and Dissertations All Schools
    Theses and Dissertations School of Medicine

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.